Global Home Medical Furniture Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 4.20 Billion |
 Market Size (Forecast Year) |
USD 20.00 Billion |
 CAGR |
% |
| Major Markets Players |
Global Digital Therapeutics Market, By Product Type (Software and Devices), Sales Channel (B2C and B2B), Application (Preventive Applications and Treatment/Care-related Applications) - Industry Trends and Forecast to 2029
Digital Therapeutics Market Analysis and Size
The global digital therapeutics market is expected to witness significant growth during the forecast period. Digital therapeutics help deliver cheaper healthcare treatment and saves a good amount of time for the patient and the healthcare provider. Rising smartphone, tablet, and other similar device penetration, combined with rising healthcare applications and software, has fueled demand for digital therapeutics. COVID-19 led a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global digital therapeutics market in the forecast period 2022-2029. The expected CAGR of global digital therapeutics market is tend to be around 21.54% in the mentioned forecast period. The market was valued at USD 4.20 billion in 2021, and it would grow upto USD 20.0 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Digital therapeutics is a part of digital healthcare that helps to prevent, manage and treat a medical condition. Moreover, it also aid in treating psychological conditions. Patient condition are improved a lot as it is evidence-based digital healthcare technology. Digital therapeutics technology is effective and efficient in diagnosing conditions that are not diagnosed otherwise by the healthcare system such as chronic diseases, neurological disorders, and much more.
Digital Therapeutics Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product Type (Software and Devices), Sales Channel (B2C and B2B), Application (Preventive Applications and Treatment/Care-related Applications) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Omada Health, Inc. (U.S.), ResMed (U.S.), Pear Therapeutics, Inc. (U.S.), Solera Network (U.S.), Akili Interactive Labs, Inc. (U.S.), Better Therapeutics, LLC (U.S.), Biofourmis (U.S.), Click Therapeutics, Inc. (U.S.), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (U.S.), Happify, Inc. (U.S.), Limbix Health, Inc. (U.S.), Voluntis (U.S.), Xealth (U.S.) |
|
Market Opportunities |
|
Global Digital Therapeutics Market Dynamics
Drivers
- Rising Chronic Diseases
The high incidence of chronic diseases along with rising demand for controlled healthcare facilities and treatment costs has boosted the demand for digital therapeutics. For instance, cardiovascular disease (CVD) is leading to the death of 17.3 million people per year, and this is expected to cross 23.6 million by 2022.
- Launch of new products
A strong line of potential products that are expected to be launched during the forecast period also provide emerging opportunities in the future. For instance, potential products of pear therapeutics, clinical therapeutics products in phase III are Pear-011 (anxiety GAD), Pear-015 (depression MDD) which are used in the treatment of chronic insomnia and depression and CT-152 (major depressive disorder), CT-155 (schizophrenia) are used in the treatment of schizophrenia and depression.
Opportunities
- Emerging Market Growth
Emerging countries such as India, China, and the Middle East present growth opportunities for digital therapeutics. Most emerging countries show high rates of the incidence of chronic disease. Developing countries like India and China lack government regulations for digital health solutions, which provide potential to healthcare professionals who cannot meet stringent standards set by FDA.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these devices could curb the growth of the global digital therapeutics market over a forecast period.
- High Cost
The huge expenditure required for manufacturing these therapeutics surely hamper the market growth. Several market players make huge investment in installing new and advanced therapeutics to faster the process and in return the cost is increased.
This global digital therapeutics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global digital therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Digital Therapeutics Market
Considering the present scenario, COVID-19 has left a major global public health crisis that has impacted largely on every business, especially healthcare. Its long-term repercussions are expected to influence industry growth during the forecast period.
Due to COVID-19, patients are increasingly shifting to digital therapeutics for disease evaluation and treatment. The COVID-19 outbreak has also compeled healthcare providers to explore alternatives to standard procedures. The COVID-19 outbreak has encouraged healthcare professionals to look for alternatives. As a result, both patients and doctors are adopting digital therapeutics increasingly.
Global Digital Therapeutics Market Scope
The global digital therapeutics market is segmented on the basis of product type, sales channel and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Software
- Devices
Sales Channel
- B2C
- B2B
Application
- Preventive Applications
- Treatment/Care-related Applications
Digital Therapeutics Market Regional Analysis/Insights
The global digital therapeutics market is analysed and market size insights and trends are provided by product type, sales channel and application as referenced above.
The major countries covered in the global digital therapeutics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to rising focus on improvement and advancement of healthcare technologies. Asia-Pacific region have highest growth due to the increased investment in healthcare infrastructure alongwith rising prevalence of chronic diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Digital Therapeutics Market Share Analysis
The global digital therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global digital therapeutics market
Key players operating in the global digital therapeutics market include:
- Omada Health, Inc. (U.S.)
- ResMed (U.S.)
- Pear Therapeutics, Inc. (U.S.)
- Solera Network (U.S.)
- Akili Interactive Labs, Inc. (U.S.)
- Better Therapeutics, LLC (U.S.)
- Biofourmis (U.S.)
- Click Therapeutics, Inc. (U.S.)
- Naturalcycles Nordic AB (Sweden)
- NuvoAir AB (Sweden)
- Welldoc’s Bluestar (U.S.)
- Happify, Inc. (U.S.)
- Limbix Health, Inc. (U.S.)
- Voluntis (U.S.)
- Xealth (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
